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Background: The magnitude of the current Zika virus (ZIKV) epidemic has led to a declaration of a Public Health
Emergency of International Concern by the WHO. Findings of viable viral particles in semen for several weeks are
corroborating reports of sexual transmission of ZIKV. Serious consequences of a positive diagnostic result
particularly in the pregnant patient are calling for precise diagnostic tools also at later time points after infection.
Currently, recommendations suggest a diagnostic period of direct viral detection of 5 to 7 days after onset of
symptoms in serum or plasma, and up to 3 weeks in urine samples.
Case presentation: A vasectomized 41-year-old German returning from Martinique presented at the outpatient
clinic of the Department for Infectious Diseases and Tropical Medicine, Munich, with subfebrile temperature, rash,
malaise, severe retro-orbital pain and occipital lymphadenopathy. The main complaints resolved after ten days
without specific treatment. We are reporting on clinical course and results of direct and indirect detection methods
of ZIKV in different sample types including whole blood, ejaculate, urine, serum, plasma and saliva samples up to
119 days post symptom onset. Ejaculate samples remained PCR positive for ZIKV until day 77, whole blood samples
until day 101.
Conclusions: The case presentation adds to the still limited knowledge of kinetics of detection of ZIKV by direct as
well as indirect methods. Here, a complete data set including results from PCR, serology and cell culture is provided
allowing an improved evaluation of optimum diagnostic periods for testing a variety of sample types. Moreover, a
high viral load of ZIKV RNA was detected in ejaculate of the vasectomized patient. This finding sheds new light on
the possible localizations of ZIKV replication in the human male reproductive tract.
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Fig. 1 Macular rash on day three after symptom onset. Source: the
photograph has been kindly provided by the patient
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Since its discovery in 1947 until 2007 only single cases
of human Zika virus (ZIKV) infections with mostly be-
nign presentations in Africa and South East Asia have
been reported [1]. The disease entity has not received
particular attention until recently, and in the 2010 edi-
tion of Harrison’s Infectious Diseases for example the in-
fection is not covered at all [2]. After smaller outbreaks
on the Yap islands and in French Polynesia, an unprece-
dented epidemic of ZIKV infections has been observed
in South America and the Caribbean since 2014, with an
estimated number of more than 1 million cases by now
in Brazil alone [3]. The concomitant appearance of
neonatal neurological malformations and cases of
Guillain-Barré-syndrome in regions affected by the ZIKV
epidemic have led to a declaration of a Public Health
Emergency of International Concern by the WHO on 01
February 2016 [4]. The potentially severe consequences
of a positive diagnosis in pregnant women are contrasted
by weaknesses in the diagnostic algorithms currently in
use. In patients presenting symptoms that are suggestive
of ZIKV infection (fever and/or rash, plus arthralgia or
arthritis or conjunctivitis) confirmation of the infection
is based on serological testing of serum samples for IgM
and IgG antibodies against ZIKV and on nucleic acid
amplification tests in serum and urine samples [5]. Sero-
logical diagnosis is regularly hampered by cross-
reactivities with antibodies against other flaviviruses
resulting from prior infections or vaccinations. For
the nucleic acid amplifications tests, the reportedly
brief diagnostic period of only 5 to 7 days when using
standard samples such as plasma and serum reduces
the diagnostic sensitivity of these very specific
methods [6]. However, the use of urine samples may
extend the detection period to up to 3 weeks [5]. Re-
ports of sexual transmission of ZIKV and the detec-
tion of ZIKV RNA in ejaculate beyond 60 days post
symptom onset make ejaculate a promising specimen
for late diagnosis of Zika in male patients [7, 8]. The
location and mechanisms of ZIKV persistence in the
male reproductive organ are not yet clearly understood.
Moreover, it is still unclear whether the prolonged detec-
tion in ejaculate is a general phenomenon in male patients
as up to now only a limited number of cases have been
investigated.
That in whole blood samples the virus may be detect-
able for longer periods of time as compared to serum
samples has previously been reported for other flavi-
viruses such as dengue virus (DENV) [9] and West Nile
virus (WNV) [10], and most recently also for ZIKV [11].
In the human case reported by us now ZIKV was de-
tected for a long period in various sample types up to
101 days post symptom onset. In addition, ZIKV could
be successfully cultured from ejaculate.Case presentation
Clinical history and physical findings
A 41-year-old male patient presented at the outpatient
clinic of the Department for Infectious Diseases and
Tropical Medicine on 30 May 2016, one day after
returning from Martinique where he had spent a two
weeks holiday with his wife and his three children. The
symptom onset was 6 days prior to presentation, still in
Martinique and started with malaise and fever. A diffuse
macular rash of the entire body (Fig. 1) developed on
the following day, accompanied by fatigue, subjective
hyperthermia, sweating, severe retro-orbital pain without
signs of conjunctivitis, general myalgia, painfully
enlarged occipital lymph nodes and pain in the elbow
joints.
The travel history revealed previous trips to Vietnam
in 2006, India in 2012, Turkey in 2014, and Guadeloupe
in 2015, without any medical history suggestive of a pre-
vious flavivirus infection. The further previous history
revealed in addition to routine immunizations vaccina-
tions against tick borne encephalitis virus and yellow
fever virus. Notably, the patient had been vasectomized
for family planning purposes in 2015. Physical examin-
ation revealed a patient in only slightly reduced general
condition and good nutritional status with an already
pale but still clearly visible macular rash. An enlarged
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tal area. The auricular temperature was 37.4 °C. The
remaining findings of the physical examination were not
remarkable. On digital palpation of the prostate no ab-
normal finding could be noted. Ultrasound investigation
of the abdomen revealed no pathological findings. The
neurological examination yielded no remarkable results.
As a suspect case of ZIKV infection according to the
case definition of WHO [12] the patient was included,
after signing an informed consent form, in an ongoing
study of ZIKV infections (“Diagnostics of Zika virus Infec-
tion in Different Body Fluids”) conducted jointly between
the Department for Infectious Diseases and Tropical
Medicine and the Department of Virology and Rickettsiol-
ogy of the Bundeswehr Institute of Microbiology (BwIM).
The study has been granted ethical clearance by the Ethics
Committee of the Ludwig-Maximilians-Universität,
Munich (opinion number 223–16).Clinical course
The patient recovered without receiving any specific
treatment. All symptoms resolved completely by 10 June,
besides a markedly depressed mood that lasted until the
end of June.Laboratory investigations
Clinical samples were collected 6, 9 and 14 days after
disease onset and from then on a weekly basis until
91 days after symptom onset. After day 91 the visit inter-
vals were prolonged due to periods of absence of the
patient. He was seen again on day 101, 112 and 119.
Specimens were transported to BwIM, and stored at
−80 °C prior to laboratory investigation.
In order to verify azoospermia in the vasectomized
patient, examination of ejaculate by microscopy was
conducted.
Nucleic acid preparation: Viral RNA was extracted
using the QIAamp viral RNA Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
Prior to extraction, ejaculate, EDTA whole blood and
saliva specimens were diluted 1:2 in nuclease free water
to avoid PCR inhibition. PCR: All specimens were inves-
tigated for the direct detection of ZIKV using the com-
mercially available real-time reverse transcriptase assay
RealStar Zika RT PCR Kit (Altona, Hamburg, Germany).
Coinfection with chikungunya virus (CHIKV) or dengue
virus in the patient was excluded by testing the serum
sample six days after symptom onset by means of the
commercially available real-time reverse transcriptase as-
says RealStar Dengue RT PCR Kit and RealStar Chikun-
gunya RT PCR Kit (both purchased from Altona,
Hamburg, Germany), respectively, according to the man-
ufacturer’s instructions.Serology
Serological testing was conducted in all serum samples
using commercially available immunofluorescence tests
for the detection of IgG and IgM antibodies against
ZIKV, DENV, CHIKV, Japanese encephalitis virus (JEV),
tick-borne encephalitis virus (TBEV), West Nile virus
(WNV) and yellow fever virus (YFV) (Euroimmun,
Lübeck, Germany). Twofold dilutions of sera were sub-
jected to endpoint titration with starting dilutions of
1:10, in order to determine IgM and IgG titers.
Cell culture
Cultural isolation in 80% confluent monolayers of African
Green Monkey kidney fibroblasts (Vero B4) and Aedes
albopictus cells (C6/36) was attempted for urine, ejaculate,
EDTA whole blood and saliva specimens. Samples were
diluted 1:10 in minimal essential medium (MEM) (Life
Technologies, Carlsbad, California, USA). Inocula of
500 μl each were added to 25 cm2 tissue culture flasks, in-
cubated at 37 °C (Vero) or 28 °C (C6/36) for 1 h, then re-
moved and replaced by 5 ml MEM containing 3% fetal
bovine serum, 1% non-essential amino acids (Life Tech-
nologies, Carlsbad, California, USA) and 3% Antibiotics/
Antimycotics Solution (Life Technologies, Carlsbad,
California, USA). Cultures were incubated at 37 °C or
28 °C for 7 days and then passaged using the procedure
described above.
All cultures were observed daily for cytopathic effects.
Also, viral growth was confirmed by Cycle Threshold
(CT) value decrease in real-time reverse transcriptase-
PCR assay between day 0 and day 7 of infection.
Sequence analysis
In order to subtype the strain of ZIKV in this patient se-
quences of two genomic regions (non-structural proteins
2b and 3 (NS2b/NS3) and 5′ untranslated region
(5UTR)) were investigated.
PCR products were obtained by conventional reverse
transcriptase-PCR. Briefly, fragments of 772 base pairs
and 345 nucleotides size were amplified from the
extracted nucleic acid using the primers Z4360 F 5′-
CTCTgTACACTCCATCTgTggTC-3′ and Z5108 R 5′-
gACAgTTAgCTgCTTCTTCTTCAg −3′(NS2b/NS3)
and the primers 5UTR F 5′- TgTTgATCTgTgTgAATCA-
gACTg −3′and 5UTR R1c 5′-CTCTTCTA-
gATCTCCgTgCTTCAC −3′ (5UTR), respectively. All
protocols were carried out using a superscript III high fi-
delity kit (Life Technologies) and an identical thermo-
profile. Briefly, 5 μl RNA, 0.4 μM forward and reverse
primers, 1 μl enzyme mix, 1 x buffer and 2.4 mM
MgSO4 were mixed and PCR-grade water was added to
a final volume of 50 μl/reaction. The thermoprofile con-
sisted of 20 min reverse transcription at 50 °C and an
initial denaturation for 2 min at 95 °C, followed by
Fig. 2 Graph of PCR CT-values in different sample types
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30 s at 68 °C and a final extension step for 7 min at 68 °C.
The obtained PCR fragments were analysed by Sanger se-
quencing conducted by an external contractor (GATC,
Konstanz, Germany). Phylogenetic tree analysis was per-
formed using the Maximum Likelihood Method based on
the Tamura-Nei model and 1000 bootstrap replicates with
Mega 5.0 [13]. Identical clusters and highly similar confi-
dence values were obtained by Maximum Parsimony
method and Neighbour-Joining method.
Routine laboratory tests including blood count and
clinical chemistry parameters as well as serological dif-
ferential diagnostics for common infectious diseases
were performed at the laboratory of the Department for
Infectious Diseases and Tropical Medicine and an exter-
nal sub-contractor.
Results
Besides slightly elevated transaminases and C-reactive
protein as well as mild micro-haematuria routine labora-
tory investigations revealed no pathological findings.
The blood group was determined as group A, Rhesus
factor positive. The Prostate Specific Antigen level in
serum was within the limits of normal.
In a native ejaculate specimen and after centrifugation
no spermatocytes could be identified by sampling 2x200
visual fields, indicating a successful vasectomy. There
were 0.7 × 106 round cells per ml ejaculate (these consist
usually of immature spermatocytes and leucocytes in a
non-vasectomized male), and among these 0.05 × 106
peroxidase positive cells per ml (indicating neutrophil
leukocytes). By microscopy neither immature spermato-
cytes nor epithelial cells were found by an experienced
examiner.
Molecular diagnostics
Initially, only a urine and a serum sample were tested
for ZIKV, DENV and CHIKV. The urine tested PCR-
positive for ZIKV on day 6 after symptom onset, while
the serum sample was found to be PCR negative for
ZIKV, DENV and CHIKV. A concurrent DENV and
CHIKV infection was thus excluded.
Weekly follow up specimens from day 9 to day 77 in-
cluded ejaculate, saliva and EDTA whole blood, in
addition to serum and urine. Urine and saliva were
found to be positive until day 14 and 21, respectively;
both sample types were again tested positive on a single
occasion on day 49 (saliva) and day 56 (urine). These re-
surgences were not accompanied by clinical symptoms
in the patient. After day 77 only collection of ejaculate
and whole blood samples was continued. Ejaculate and
whole blood were tested positive for ZIKV by PCR until
day 77 and 101 respectively. Collection of ejaculate sam-
ples was discontinued after day 91 when the secondconsecutive negative result was obtained. The follow-up
period was closed on day 119 when for the whole blood
samples the second consecutive negative result was
obtained (Fig. 2).
Serum and plasma samples did not yield any positive
PCR-results throughout the investigation period. Detailed
results are displayed in Table 1.
Serology
IgM antibodies were exclusively reactive against ZIKV
antigen while for IgG a broad reactivity with other flavi-
viruses (DENV, JEV, TBEV, WNV and YFV) was ob-
served. No IgM or IgG antibodies against CHIKV were
observed throughout the whole investigation period.
Anti-ZIKV IgM antibodies reached their peak on day 9
and turned undetectable on day 49, while anti-ZIKV IgG
antibodies reached their peak on day 14 and remained
detectable at a stable titer level until the end of the ob-
served period. The serological course of ZIKV and
DENV IgM and IgG is depicted in Fig. 3.
Virus isolation
A ZIKV strain was isolated in both cell lines from an
ejaculate sample collected on day 9, but only in Aedes
albopictus cells in an ejaculate sample from day 21 post
symptom onset. The strain was designated TM 100.16
ZIKV Martinique. Attempts for virus isolation from
other sample types remained unsuccessful.
Sequence analysis of the isolated ZIKV strain
Sequencing of PCR amplicons of the ZIKV strain isolated
from the patient revealed an Asian strain of ZIKV. The
phylogenetic tree that was constructed for non-structural
proteins 2b and 3 (Fig. 4) and for the 5′ untranslated
region (Fig. 5) by sequence alignment with reference data
located the identified strain in close proximity to strains
already identified in 2015 in Martinique, and in 2016 in
Colombia and Mexico.
Table 1 Sample types and test results of laboratory examinations for ZIKV up to day 119 post symptom onset
PCR Results (CT-values) Cell Culture Serology Titers
Days after symptom onset Urine Saliva Whole Blood Ejaculate Ejaculate IgM IgG
day 6 pos (21.75) nd nd nd nd 160 640
day 9 pos (23.67) pos (31.47) pos (30.75) pos (12.07) pos 640 5120
day 14 pos (30.44) pos (33.79) pos (31.71) pos (13.45) neg 320 10240
day 21 neg pos (32.41) pos (32.39) pos (22.36) pos 160 5120
day 28 neg neg pos (32.45) pos (24.72) neg 40 2560
day 35 neg neg pos (34.01) pos (27.19) neg 10 2560
day 42 neg neg pos (33.35) pos (29.40) neg 10 2560
day 49 neg pos (32.87) pos (34.70) pos (30.39) nd neg 2560
day 56 pos (34.1) neg pos (33.1) pos (31.77) nd neg 2560
day 63 neg neg pos (33.95) pos (35.40) nd neg 2560
day 70 neg neg pos (32.66) neg nd neg 2560
day 77 nd neg pos (34.14) pos (34.34) nd neg 2560
day 84 nd nd pos (33.05) neg nd neg 1280
day 91 nd nd pos (33.92) neg nd nd nd
day 101 nd nd pos (34.42) nd nd nd nd
day 112 nd nd neg nd nd neg 1280
day 119 nd nd neg nd nd nd nd
ZIKV positive test results are typed in bold face. Only test results for sample types that tested positive at least once during the sampling period are shown. pos
positive, neg negative, nd not determined
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The ZIKV epidemic in Latin America is also affecting
German travellers returning from regions with circulat-
ing ZIKV infections. We are reporting a profound
follow-up investigation in a vasectomized patient with
ZIKV infection providing a detailed dataset of serological
as well as molecular parameters elucidating the kinetics
of ZIKV RNA presence in various sample types. We also
contribute the results of our isolation attempts and theFig. 3 Course of IgM and IgG response against ZIKV and DENV. IgM
antibodies were exclusively reactive against ZIKV antigen while for
IgG a broad reactivity against other flaviviruses was observed (data
only shown for DENV)sequence data of a new ZIKV strain. ZIKV RNA was de-
tected over a long period of time up to 77 days post
symptom onset in ejaculate and up to 101 days in whole
blood samples of the patient. The prolonged detectability
of viral RNA has recently been reported for some sam-
ple types such as ejaculate [7] saliva [14] or whole blood
[11] by other authors, as well as the possibility of a re-
surgence of positive PCR results in saliva after prior con-
version to negative [14]. The intermittent detection of
ZIKV RNA in urine as demonstrated in this study might
be interpreted as contamination due to the very close
temporal relation of the collection of urine and ejaculate
samples.
Notably, the patient has been successfully vasecto-
mized in 2015. Thus, the persistence of ZIKV in the uro-
genital tract in males, or at least its location of shedding,
which is still poorly understood in humans, can be nar-
rowed down in the patient described in this study to the
compartments of Cowper’s glands, the prostate gland
and seminal vesicles; the latter two contributing the
largest fractions to the ejaculate volume. The low CT-
values found in ejaculate specimens and the prolonged
detectability of viable ZIKV in this body fluid indicate
that ZIKV might not only persist, but also replicate in a
yet not clearly defined compartment of the male uro-
genital tract. ZIKV persistence in patients with clinical
signs of prostatitis has been reported elsewhere [15].
However, our patient did not show any clinical signs of
Fig. 4 Phylogenetic tree analysis for NS2b and NS3 of ZIKV strain TM 100.16. Phylogenetic tree analysis of a 772 nucleotide partial segment of
NS2b and NS3 by Maximum Likelihood method based on the Tamura-Nei model and 1000 bootstrap replicates with Mega 5.0; the patient isolate
TM 100.16 ZIKV Martinique is highlighted in bold (scale bar indicates number of nucleotide substitutions per site)
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is not a prerequisite for replication of ZIKV in this com-
partment. A recent report on another vasectomized
patient returning from the Maldives also found ZIKV in
ejaculate samples. There, a potentially sexual transmis-
sion to a partner has been discussed. However, the possi-
bility of a mosquito-borne transmission in the wife
cannot be entirely ruled out as she had accompanied theFig. 5 Phylogenetic tree analysis for the 5′untranslated region of ZIKV strain
segment of the 5′untranslated region by Maximum Likelihood method bas
5.0; the isolate TM 100.16 ZIKV Martinique is highlighted in bold (scale barindex patient on the visit to the Maldives, and her symp-
toms started only 18 days after their return [16]. Mansuy
et al. demonstrated the presence of ZIKV particles in the
heads of spermatocytes [17]. In an attempt to identify
the compartment in ejaculate harbouring ZIKV particles,
Barzon et al. investigated both seminal plasma and the
cellular compartment of ejaculate samples positive for
ZIKV. They found ZIKV nucleic acids exclusively in theTM 100.16. Phylogenetic tree analysis of a 608 nucleotide partial
ed on the Tamura-Nei model and 1000 bootstrap replicates with Mega
indicates number of nucleotide substitutions per site)
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a successfully vasectomized patient spermatocytes could
be excluded as carriers of viral particles, it therefore may
be speculated that other cellular elements may be in-
volved, namely the round and peroxidase positive cells
that were found in the ejaculate of our patient. These
cells are either immature sperm forms (e.g. spermato-
cytes) or inflammatory cells (like neutrophils, lympho-
cytes, macrophages and epithelial cells) [19]. In this
patient presence of both immature spermatocytes and
epithelial cells could be ruled out, therefore at large the
cellular compartment of the ejaculate consisted of leuko-
cytes. Also, the location of ZIKV particles in the male
genitourinary tract might be variable and even the possi-
bility that ZIKV might be capable to attach to a diverse
number of cell types and thus be distributed in the or-
ganism has to be considered. In the future, investigations
are needed to shed light on the anatomical location of
viral persistence and the exact compartment in ejaculate
that is responsible for the shedding and carriage of viral
particles.
The successful cell-cultural isolation of ZIKV from the
ejaculate in this patient demonstrated viability of the
virus until at least 21 days post symptom onset. The fail-
ure of cell cultural isolation beyond this point of time
might have been caused by deterioration of the viability of
the virus due to low pH or other specimen-dependent in-
fluencing factors, as recently proposed by other authors
[20, 21]. Thus, the potential of sexual transmission for a
much longer period in this patient cannot be ruled out.
A prolonged isolation of viral RNA in whole blood
samples has previously been proven for other flavi-
viruses, e.g. by Klungthong et al. for dengue virus [9] or
by Lanteri et al. for West Nile virus [10]. In the latter
publication, a correlation between blood group A and
higher viral loads has been claimed, possibly indicating
an attachment of viral particles to erythrocyte mem-
branes. Our patient has also blood group A.
Our results also indicate that ZIKV particles might be
bound to cellular structures, because serum samples re-
covered from the same venepuncture as well as plasma
samples obtained after centrifugation of a ZIKV positive
whole blood sample were tested negative for ZIKV RNA.
To clarify the exact localization of ZIKV particles in the
cell compartment in blood, further analyses of distinct
fractions of whole blood including the buffy coat, as well
as imaging techniques such as electron microscopy and
fluorescence in situ hybridization techniques in add-
itional patients are planned.
Our data provide some evidence that during the late
course of the disease, whole blood may be the type of
sample giving the best diagnostic sensitivity. Current
guidelines in vigour are suggesting collection of serum
samples until day 7 after symptom onset, and of urineuntil day 21 for direct detection of viral RNA. Investiga-
tions at later time points are based on serological, thus
indirect detection methods. Based on findings of differ-
ent groups that parallel our results, sample types have
been suggested for later direct detection of ZIKV RNA,
such as saliva or whole blood [11, 14]. Based on the re-
sults of this study, whole blood seems to be the most
promising candidate for late detection of viral particles
in patients, especially, when IgM antibodies are no
longer detectable. Ejaculate is another option in male pa-
tients and also allows late direct diagnosis, but is less
suitable in routine diagnostics due to the restriction to
male patients and the effort of specimen collection
Therefore, it should be mainly considered as diagnostic
sample for certain clinical settings, such as fertility
clinics or couples wishing to become pregnant that
travel frequently to or are residing in endemic regions.
In addition, examination of ejaculate samples may be a
means to rule out further infectiousness in male patients
originating from non-endemic regions after having com-
pleted the recommended six months of sexual barrier
protection, especially in couples that wish to conceive.
In terms of infection prevention, different current na-
tional and international guidelines have adapted their
recommendations concerning sexual barrier protection
for persons returning from ZIKV endemic countries.
The periods of recommended use of barrier protection,
such as condoms, is currently set to six months after re-
turn from an endemic region. These time frames are
based on reports of observations of direct ZIKV detec-
tion in ejaculate, such as in this patient, rounded up by a
safety time buffer [22, 23].
Saliva samples seem to be another suitable routine
specimen type in the acute phase of the infection, with a
slightly longer persistence time than in urine, but seem
to remain positive for shorter periods than whole blood
specimens. Saliva specimens may particularly be consid-
ered in situations where processing of blood samples
may be difficult, such as in paediatric populations or in
screening activities either of large populations or in low
resource settings.
The long duration of detectability of viral RNA, and
possibly also of viable and therefore infectious virions in
whole blood presents a challenge to medical uses of human
blood products. A risk of transmission of ZIKV by blood-
donors as well as platelet donors has been reported
recently [24]. It appears reasonable to suggest that blood
donors need to be screened for potential exposure to ZIKV,
and individuals fulfilling criteria of potential exposure
(such as travelling in ZIKV endemic countries or having
had sexual contact to a person that has travelled to ZIKV
endemic countries within the past six months) should have
a whole blood sample tested directly by PCR as well as
indirectly by serological testing prior to donation.
Froeschl et al. BMC Infectious Diseases  (2017) 17:55 Page 8 of 9The serological profile in our patient revealed an ex-
pectable dynamic with an earlier peak in anti-ZIKV IgM
antibodies as compared to anti-ZIKV IgG antibodies. On
day 49, anti-ZIKV IgM antibodies were not detectable
any more. As shown in Fig. 3, anti-DENV IgG antibodies
also showed an early increase, while at no time point
anti-DENV IgM antibodies were detectable. The IgG
and IgM antibodies of the other investigated flaviviruses
(JEV, TBEV, WNV and YFV) showed profiles similar to
DENV. Since the patient had no medical history suggest-
ive of a previous flavivirus infection but has been vacci-
nated against TBEV and YFV several years ago, it may
be argued whether the IgG antibody profiles in assays
directed at flaviviruses other than ZIKV developed due
to cross-reactions between anti-ZIKV antibodies and the
used immunofluorescence based serological assays, or
whether an immunological memory that had been
primed by previous vaccinations or unrecognized flavivi-
rus infections underwent a bystander activation in the
current course of an acute ZIKV infection.
In summary, the results of this case enhance the
knowledge about long-term kinetics of direct and indirect
ZIKV detection methods and moreover about possible
locations for persistence of ZIKV in whole blood and the
male reproductive tract.
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